Literature DB >> 19182914

Preparation and antioxidant activity of green tea extract enriched in epigallocatechin (EGC) and epigallocatechin gallate (EGCG).

Jianhui Hu1, Danrong Zhou, Yuqiong Chen.   

Abstract

The present study investigated effects of solvents, temperature, and duration on extracting efficiency of catechins from green tea by an orthogonal test. The results suggested that extraction of epigallocatechin gallate (EGCG) was highly dependent on these factors, whereas that of epigallocatechin (EGC) was significantly affected by duration and solvent (P < 0.05). Effects of these factors on epicatechin (EC), catechin (C), and epicatechin gallate (ECG) were not significant. A two-step preparation was adopted to produce green tea extract enriched in EGC (GTE-EGC) and green tea extract enriched in EGCG (GTE-EGCG). The optimum conditions for GTE-EGC were that green tea was brewed in 75% ethanol at 30 degrees C for 10 min, whereas for GTE-EGCG the same tea was brewed in 35% ethanol at 90 degrees C for 60 min. Compared with GTE-EGC, GTE-EGCG had EGCG increased by 110.42%, whereas EGC decreased by 40.38% with EC and ECG being unchanged. Most importantly, GTE-EGCG possessed greater antioxidant activity (in vitro) than GTE-EGC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19182914     DOI: 10.1021/jf803143n

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  8 in total

1.  A derivative of epigallocatechin-3-gallate induces apoptosis via SHP-1-mediated suppression of BCR-ABL and STAT3 signalling in chronic myelogenous leukaemia.

Authors:  Ji Hoon Jung; Miyong Yun; Eun-Jeong Choo; Sun-Hee Kim; Myoung-Seok Jeong; Deok-Beom Jung; Hyemin Lee; Eun-Ok Kim; Nobuo Kato; Bonglee Kim; Sanjay K Srivastava; Kunihiro Kaihatsu; Sung-Hoon Kim
Journal:  Br J Pharmacol       Date:  2015-06-04       Impact factor: 8.739

2.  Functional analysis of the dihydroflavonol 4-reductase family of Camellia sinensis: exploiting key amino acids to reconstruct reduction activity.

Authors:  Haixiang Ruan; Xingxing Shi; Liping Gao; Arif Rashid; Yan Li; Ting Lei; Xinlong Dai; Tao Xia; Yunsheng Wang
Journal:  Hortic Res       Date:  2022-04-22       Impact factor: 7.291

3.  Epigallocatechin-3-gallate increases maximal oxygen uptake in adult humans.

Authors:  Jennifer C Richards; Mark C Lonac; Tyler K Johnson; Melani M Schweder; Christopher Bell
Journal:  Med Sci Sports Exerc       Date:  2010-04       Impact factor: 5.411

4.  Characterization of Epigallocatechin-Gallate-Grafted Chitosan Nanoparticles and Evaluation of Their Antibacterial and Antioxidant Potential.

Authors:  María J Moreno-Vásquez; Maribel Plascencia-Jatomea; Saúl Sánchez-Valdes; Judith C Tanori-Córdova; Francisco J Castillo-Yañez; Idania E Quintero-Reyes; Abril Z Graciano-Verdugo
Journal:  Polymers (Basel)       Date:  2021-04-23       Impact factor: 4.329

5.  Tea consumption and risk of ischaemic heart disease.

Authors:  Xia Li; Canqing Yu; Yu Guo; Zheng Bian; Jiahui Si; Ling Yang; Yiping Chen; Xiaolan Ren; Ge Jiang; Junshi Chen; Zhengming Chen; Jun Lv; Liming Li
Journal:  Heart       Date:  2017-01-11       Impact factor: 5.994

6.  Association between tea consumption and risk of cancer: a prospective cohort study of 0.5 million Chinese adults.

Authors:  Xinyi Li; Canqing Yu; Yu Guo; Zheng Bian; Zewei Shen; Ling Yang; Yiping Chen; Yongyue Wei; Hao Zhang; Zhe Qiu; Junshi Chen; Feng Chen; Zhengming Chen; Jun Lv; Liming Li
Journal:  Eur J Epidemiol       Date:  2019-05-31       Impact factor: 8.082

Review 7.  Advances in the Antagonism of Epigallocatechin-3-gallate in the Treatment of Digestive Tract Tumors.

Authors:  Changwei Liu; Penghui Li; Zhihao Qu; Wei Xiong; Ailing Liu; Sheng Zhang
Journal:  Molecules       Date:  2019-05-03       Impact factor: 4.411

8.  The In Vitro Anti-Inflammatory Activities of Galangin and Quercetin towards the LPS-Injured Rat Intestinal Epithelial (IEC-6) Cells as Affected by Heat Treatment.

Authors:  Shi-Qing Cai; Qiang Zhang; Xin-Huai Zhao; Jia Shi
Journal:  Molecules       Date:  2021-12-10       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.